The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Universal Health Services Inc

NYSE: UHS
Last

(U.S.) $104.18

Today's change-0.29 -0.28%
Updated February 9 11:11 AM EST. Delayed by at least 15 minutes.
 

Universal Health Services Inc

NYSE: UHS
Last

(U.S.) $104.18

Today's change-0.29 -0.28%
Updated February 9 11:11 AM EST. Delayed by at least 15 minutes.

Universal Health Services Inc down (U.S.)$0.29

Universal Health Services Inc is lower today, dropping (U.S.)$0.29 or 0.28% to (U.S.)$104.18. Over the last five days, shares have lost 7.07% and sit 1.28% above their 52-week low. This security has outperformed the S&P 500 by 9.82% during the last year.

Key company metrics

  • Open(U.S.) $103.29
  • Previous close(U.S.) $104.47
  • High(U.S.) $105.74
  • Low(U.S.) $102.99
  • Bid / Ask(U.S.) $104.21 / (U.S.) $104.53
  • YTD % change-12.81%
  • Volume114,019
  • Average volume (10-day)649,978
  • Average volume (1-month)728,307
  • Average volume (3-month)798,458
  • 52-week range(U.S.) $102.86 to (U.S.) $148.57
  • Beta1.44
  • Trailing P/E15.47×
  • P/E 1 year forward15.21×
  • Forward PEG1.32×
  • Indicated annual dividend(U.S.) $0.40
  • Dividend yield0.38%
  • Trailing EPS(U.S.) $6.73
Updated February 9 11:11 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.49%

Based on its net profit margin of 8.49%, Universal Health Services Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.76%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue2,2282,2752,2252,108
Total other revenue--------
Total revenue2,2282,2752,2252,108
Gross profit--------
Total cost of revenue--------
Total operating expense1,9521,9401,8981,785
Selling / general / administrative1,3241,3081,2931,251
Research & development--------
Depreciation / amortization99979998
Interest expense (income), net operating--------
Unusual expense (income)0----0
Other operating expenses, total529534506436
Operating income275335327322
Interest income (expense), net non-operating-26-26-26-27
Gain (loss) on sale of assets--------
Other--------
Income before tax248308297291
Income after tax164201194190
Income tax, total84106103101
Net income150182174173
Total adjustments to net income0000
Net income before extra. items150182174173
Minority interest-13-19-20-18
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items150182174173
Inc. avail. to common incl. extra. items150182174173
Diluted net income150182174173
Dilution adjustment0------
Diluted weighted average shares101101101101
Diluted EPS excluding extraordinary itemsvalue per share1.481.801.731.71
Dividends per sharevalue per share0.100.100.100.10
Diluted normalized EPSvalue per share1.481.801.731.71